Motor cortical inhibition and the dopaminergic system: Pharmacological changes in the silent period after transcranial brain stimulation in normal subjects, patients with parkinson's disease and drug-induced parkinsonism

Brain

Volumn 117, Issue 2, 1994, Pages 317-323

  Priori, A ^a   Berardelli, A ^a   Inghilleri, M ^a   Accornero, N ^a   Manfredi, M ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Cortical stimulation; Dopaminergic system; Motor cortex; Neuroleptic drugs; Parkinson's disease

Indexed keywords

BENSERAZIDE; BIPERIDEN; CHOLINERGIC RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; DRUG; LEVODOPA; NEUROLEPTIC AGENT;

ADULT; AGED; ARTICLE; BRAIN DEPTH STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOPAMINERGIC SYSTEM; DRUG INDUCED DISEASE; ELECTROMYOGRAM; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOTOR CORTEX; NERVE STIMULATION; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PARKINSONISM; PRIORITY JOURNAL;

ADULT; AGED; BIPERIDEN; BRAIN; ELECTRIC STIMULATION; EVOKED POTENTIALS; FEMALE; HUMAN; LEVODOPA; MAGNETICS; MALE; MIDDLE AGE; MOTOR CORTEX; MUSCLES; PARKINSON DISEASE; PARKINSON DISEASE, SECONDARY; PERIPHERAL NERVES;

EID: 0028342382     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/117.2.317     Document Type: Article

References (37)

1. Alexander G.E, Crutcher M.D. Functional architecture of basal ganglia circuits: neural substrates of parallel processing [see comments], [Review], Trends Neurosci 1990; 13: 266—71. Comment in: Trends Neurosci 1991; 14: 55-59
2. Angel RW, Hofmann WW, Eppler W. Silent period in patients with parkinsonian rigidity. Neurology 1966; 16: 529-32
3. Berger B, Gaspar P, Verney C. Dopaminergic innervation of the cerebral cortex: unexpected differences between rodents and primates [published erratum appears in Trends Neurosci 1991; 14: 119]. [Review], Trends Neurosci 1991; 14: 21—7
4. Bradley PB. Introduction to neuropharmacology. London: Wright, 1989
5. Cantello R, Gianelli M, Bettucci D, Civardi C, De Angelis MS, Mutani R. Parkinson’s disease rigidity: magnetic motor evoked potentials in a small hand muscle. Neurology 1991; 41: 1449 -1456
6. Cantello R, Gianelli M, Civardi C, Mutani R. Magnetic brain stimulation: the silent period after the motor evoked potential. Neurology 1992; 42: 1951-1959
7. DeLong MR. Primate models of movement disorders of basal ganglia origin. [Review]. Trends Neurosci 1990; 13: 281-5
8. Dick JPR, Cowan JMA, Day BL, Berardelli A, Kachi T, Rothwell JC el al. The corticomotoneurone connection is normal in Parkinson’s disease. Nature 1984; 310: 407-409
9. Dick JPR, Cantello R, Buruma O, Gioux M, Benecke R, Day BL et al. The Bereitschaftspotential, L-DOPA and Parkinson’s disease. Electroencephalogr Clin Neurophysiol 1987; 66: 263-74
10. Dietrichson P. The silent period in spastic, rigid and normal subjects during isotonic and isometric muscle contractions. Acta Neurol Scand 1971; 47: 183-93
11. Ferbert A, Priori A, Rothwell JC, Day BL, Colebatch JG, Marsden CD. Interhemispheric inhibition of the human motor cortex. J Physiol (Lond) 1992; 453: 525-546
12. Fuhr P, Agostino R, Hallett M. Spinal motor neuron excitability during the silent period after cortical stimulation. Electroencephalogr Clin Neurophysiol 1991; 81: 257-262
13. Gaspar P, Duyckaerts C, Alvarez C, Javoy-Agid F, Berger B. Alterations of dopaminergic and noradrenergic innervations in motor cortex in Parkinson’s disease. Ann Neurol 1991; 30: 365-374
14. Higgins DC, Haidri NH, Wilboum AJ. Muscle silent period in Parkinson’s disease. J Neurol Neurosurg Psychiatry 1971; 34: 508-511
15. Hufschmidt HJ. Über die reflektorische Grundlage des Parkinson tremors. Dt Z Nervheilk 1959; 179: 298-308
16. Inghilleri M, Berardelli A, Cruccu G, Manfredi M. Silent period evoked by transcranial stimulation of the human cortex and cervicomedullary junction. J Physiol (Lond) 1993; 466: 521-34
17. Kukowski B, Haug B. Quantitative evaluation of the silent period, evoked by transcranial magnetic stimulation during sustained muscle contraction, in normal man and in patients with stroke. Electromyogr Clin Neurophysiol 1992; 32: 373 -378
18. Lindvall O, Bjorklund A, Divac I. Organization of catecholamine neurons projecting to the frontal cortex in the rat. Brain Res 1978; 142: 1-24
19. McLellan DL. Levodopa in parkinsonism: reduction in the electromyographic silent period and its relationship with tremor. J Neurol Neurosurg Psychiatry 1972; 35: 373-8
20. Mantz J, Milia C, Glowinski J, Thierry AM. Differential effects of ascending neurons containing dopamine and noradrenaline in the control of spontaneous activity and of evoked responses in the rat prefrontal cortex. Neuroscience 1988; 27: 517-526
21. Marsden CD, Merton PA, Morton HB. Direct electrical stimulation of corticospinal pathways through the intact scalp in human subjects. Adv Neurol 1983; 39: 387-91
22. Merton PA. The silent period in a muscle of the human hand. J Physiol (Lond) 1951; 114: 183-198
23. Nakashima K, Takahashi K. Silent periods in the abductor pollicis brevis muscle in patients with Parkinson’s disease. Electromyogr Clin Neurophysiol 1992; 32: 215-19
24. Niemegeers CJE, Janssen PAJ. A systematic study of the pharmacological activities of dopamine antagonists. [Review], Life Sci 1979; 24: 2201-16
25. Pinelli P. Studi sul tremore Parkinsoniano. Analisi degli effetti della stimolazione del nervo ed altri contributi elettromiografici di interesse fisiopatogenetico. Boll Soc Med Chir (Pavia) 1955; 69: 877—901
26. Priori A, Inghilleri M, Berardelli A. Transcranial brain stimulation in basal ganglia disorders. In: Lissens MA, editor. Clinical application of magnetic transcranial stimulation. Leuven: Peeters Press, 1992; 175-84
27. Priori A, Berardelli A, Inghilleri M, Polidori L, Manfredi M. Electromyographic silent period after transcranial brain stimulation in Huntington’s disease. Mov Disord 1994. In press
28. Roick H, Giesen HJ, Lange HW, Benecke R. Postexcitatory inhibition in Huntington’s disease [abstract]. Mov Disord 1992; 7 Suppl 1: 27
29. Roick H, von Giesen HJ, Benecke R. On the origin of the postexcitatory inhibition seen after transcranial magnetic brain stimulation in awake human subjects. Exp Brain Res 1993; 94: 489-498
30. Sawaguchi T, Matsumura M, Kubota K. Catecholamine sensitivities of motor cortical neurons of the monkey. Neurosci Lett 1986; 66: 135-140
31. Shahani BT, Young RR. Studies of the normal human silent period. In: Desmedt JE, editor. Human reflexes: pathophysiology of motor systems: methodology of human reflexes. New developments in electromyography and clinical neurophysiology, Vol 3. Basel: S. Karger, 1973: 589-602
32. Tatton WG, Lee RG. Evidence for abnormal long-loop reflexes in rigid parkinsonian patients. Brain Res 1975; 100: 671-676
33. Thierry AM, Tassin JP, Glowinski J. Biochemical and electrophysiological studies of the mesocortical dopamine system. In: Descarries L, Reader TR, Jasper HH, editors. Monoamine innervation of cerebral cortex. New York: Alan R. Liss, 1984: 233-61
34. Triggs WJ, Macdonell RAL, Cros D, Chiappa KH, Shahani BT, Day BJ. Motor inhibition and excitation are independent effects of magnetic cortical stimulation. Ann Neurol 1992; 32: 345-351
35. Uozumi T, Ito Y, Tsuji S, Murai Y. Inhibitory period following motor potentials evoked by magnetic cortical stimulation. Electroencephalogr Clin Neurophysiol 1992; 85: 273-279
36. Wassermann EM, Fuhr P, Cohen LG, Hallett M. Effects of transcranial magnetic stimulation on ipsilateral muscles [published erratum appears in Neurology 1992; 42: 1115]. Neurology 1991; 41: 1795-1799
37. Wilson SA, Lockwood RJ, Thickbroom GW, Mastaglia FL. The muscle silent period following transcranial magnetic cortical stimulation. J Neurol Sci 1993; 114: 216-222